5093 | Humans |
3037 | Female |
2824 | Male |
1542 | Middle Aged |
1487 | Adult |
1302 | Animals |
1159 | Aged |
686 | Adolescent |
657 | Young Adult |
576 | Treatment Outcome |
484 | Aged, 80 and over |
474 | Retrospective Studies |
473 | Child |
459 | Mice |
420 | Risk Factors |
343 | United States |
314 | Time Factors |
305 | Prospective Studies |
305 | Follow-Up Studies |
247 | Cohort Studies |
234 | Child, Preschool |
217 | Surveys and Questionnaires |
200 | Prognosis |
195 | Reproducibility of Results |
190 | Disease Models, Animal |
184 | Infant |
180 | Rats |
176 | Pregnancy |
173 | Magnetic Resonance Imaging |
172 | Cross-Sectional Studies |
170 | United States (epidemiology) |
170 | Age Factors |
162 | Case-Control Studies |
161 | Mice, Inbred C57BL |
152 | Cell Line, Tumor |
149 | Severity of Illness Index |
149 | Cells, Cultured |
135 | Longitudinal Studies |
132 | Rats, Sprague-Dawley |
129 | Incidence |
128 | Algorithms |
122 | Predictive Value of Tests |
117 | Infant, Newborn |
113 | Mutation |
112 | Signal Transduction |
112 | Risk Assessment |
112 | Phenotype |
110 | Cell Line |
101 | Sensitivity and Specificity |
100 | Mice, Knockout |
100 | Body Mass Index |
99 | Genotype |
98 | Logistic Models |
95 | Computer Simulation |
92 | Pennsylvania |
89 | Quality of Life |
88 | Tomography, X-Ray Computed |
88 | Comorbidity |
87 | Prevalence |
86 | Models, Biological |
84 | Protein Binding |
82 | Sex Factors |
81 | Neoplasm Staging |
80 | Molecular Sequence Data |
80 | Disease Progression |
79 | Neuropsychological Tests |
79 | Immunohistochemistry |
78 | Models, Molecular |
77 | Magnetic Resonance Imaging (methods) |
76 | Mice, Transgenic |
76 | Genetic Predisposition to Disease |
73 | Dose-Response Relationship, Drug |
71 | Survival Rate |
71 | Multivariate Analysis |
71 | Diagnosis, Differential |
70 | Kaplan-Meier Estimate |
70 | Cell Proliferation |
68 | Biomarkers (blood) |
66 | Proportional Hazards Models |
64 | Equipment Design |
62 | Polymorphism, Single Nucleotide |
61 | Survival Analysis |
61 | Double-Blind Method |
61 | Amino Acid Sequence |
59 | Pilot Projects |
58 | Biomechanical Phenomena |
57 | Risk |
57 | Databases, Factual |
56 | Disease-Free Survival |
54 | Socioeconomic Factors |
54 | Linear Models |
54 | Combined Modality Therapy |
53 | Radiography |
53 | Practice Guidelines as Topic |
53 | Models, Theoretical |
53 | Antineoplastic Combined Chemotherapy Protocols (therapeutic use) |
52 | Self Report |
52 | Pennsylvania (epidemiology) |
52 | Brain (pathology) |
51 | Registries |
51 | Recurrence |
51 | Psychiatric Status Rating Scales |
51 | Odds Ratio |
51 | Breast Neoplasms (pathology) |
51 | Analysis of Variance |
50 | Randomized Controlled Trials as Topic |
50 | HEK293 Cells |
50 | Gene Expression Profiling |
50 | Apoptosis (drug effects) |
49 | Kinetics |
49 | Decision Making |
49 | Antineoplastic Agents (therapeutic use) |
48 | Biopsy |
48 | Base Sequence |
48 | Acute Disease |
47 | Models, Statistical |
47 | Gene Expression |
47 | Brain (physiology) |
47 | Aging (physiology) |
46 | ROC Curve |
46 | Genome-Wide Association Study |
45 | Image Processing, Computer-Assisted |
44 | Gene Expression Regulation |
44 | Depression (psychology) |
44 | Alleles |
43 | Phosphorylation |
43 | Mice, Inbred BALB C |
43 | Interpersonal Relations |
43 | HIV Infections (drug therapy) |
42 | Software |
42 | Signal Transduction (drug effects) |
42 | Regression Analysis |
42 | Health Knowledge, Attitudes, Practice |
42 | Feasibility Studies |
42 | Evidence-Based Medicine |
42 | Biomarkers (metabolism) |
41 | Neurons (physiology) |
41 | Anti-Bacterial Agents (therapeutic use) |
40 | Patient Selection |
40 | Cognition (physiology) |
40 | Blotting, Western |
39 | Signal Transduction (physiology) |
39 | RNA Interference |
39 | Protein Structure, Tertiary |
39 | Neurons (metabolism) |
38 | Macaca mulatta |
38 | Breast Neoplasms (drug therapy) |
38 | Apoptosis |
37 | Tomography, X-Ray Computed (methods) |
37 | Swine |
37 | RNA, Messenger (metabolism) |
37 | Obesity (complications) |
37 | Mitochondria (metabolism) |
37 | Clinical Trials as Topic |
37 | Cell Proliferation (drug effects) |
36 | Weight Loss |
36 | Patient Satisfaction |
36 | Motor Activity |
36 | Mice, Nude |
36 | Communication |
36 | Chronic Disease |
36 | Cell Differentiation |
36 | Brain Mapping |
36 | Brain (metabolism) |
35 | Cytokines (metabolism) |
35 | Cost-Benefit Analysis |
35 | Brain (physiopathology) |
34 | RNA, Messenger (genetics) |
34 | Protein Conformation |
34 | Oxidation-Reduction |
34 | Outcome Assessment (Health Care) |
34 | Gene Expression Regulation, Neoplastic |
34 | Drug Therapy, Combination |
34 | Cognition |
34 | Adenocarcinoma (pathology) |
34 | Activities of Daily Living |
33 | Sequence Analysis, DNA |
33 | Reoperation |
33 | Lung Neoplasms (pathology) |
33 | Lung (pathology) |
33 | Internet |
33 | Health Status |
33 | Carcinoma, Squamous Cell (pathology) |
32 | Phylogeny |
32 | HIV Infections (virology) |
31 | Ultrasonography |
31 | Polymorphism, Single Nucleotide (genetics) |
31 | Dendritic Cells (immunology) |
31 | Biomarkers, Tumor (metabolism) |
31 | Antineoplastic Agents (pharmacology) |
30 | Real-Time Polymerase Chain Reaction |
30 | Psychometrics |
30 | Neoplasms (therapy) |
30 | Membrane Proteins (metabolism) |
30 | Forecasting |
30 | Depression (epidemiology) |
30 | Biomarkers, Tumor (analysis) |
30 | Adaptation, Psychological |
29 | Transcription Factors (metabolism) |
29 | Tissue Engineering (methods) |
29 | Survival Rate (trends) |
29 | Societies, Medical |
29 | Smoking (epidemiology) |
29 | Reward |
29 | Research Design |
29 | Models, Neurological |
29 | Emotions |
29 | Drug Administration Schedule |
29 | Attitude of Health Personnel |
28 | User-Computer Interface |
28 | Polymerase Chain Reaction |
28 | Molecular Dynamics Simulation |
28 | Microscopy, Fluorescence |
28 | Heart Failure (therapy) |
28 | Health Behavior |
27 | Transfection |
27 | Temperature |
27 | Social Support |
27 | Smoking (psychology) |
27 | Promoter Regions, Genetic |
27 | Positron-Emission Tomography |
27 | Polymers (chemistry) |
27 | Parent-Child Relations |
27 | Mutation (genetics) |
27 | Microscopy, Confocal |
27 | Microbial Sensitivity Tests |
27 | Lung (metabolism) |
27 | Life Style |
27 | Inflammation (metabolism) |
27 | European Continental Ancestry Group (statistics & numerical data) |
27 | Cell Survival (drug effects) |
27 | Biomarkers, Tumor (genetics) |
27 | Binding Sites |
27 | Area Under Curve |
27 | Anterior Cruciate Ligament (surgery) |
27 | Aging |
27 | Age of Onset |
26 | Transcription Factors (genetics) |
26 | Skin Neoplasms (pathology) |
26 | Protein Transport |
26 | Postoperative Complications |
26 | Pain Measurement |
26 | Neoplasm Metastasis |
26 | European Continental Ancestry Group |
26 | Enzyme-Linked Immunosorbent Assay |
26 | Clinical Competence |
26 | Cell Movement |
26 | Antineoplastic Agents (administration & dosage) |
25 | Thermodynamics |
25 | Stress, Mechanical |
25 | Social Behavior |
25 | Reference Values |
25 | Reactive Oxygen Species (metabolism) |
25 | Photic Stimulation |
25 | Motor Activity (physiology) |
25 | Liver (pathology) |
25 | Length of Stay |
25 | Genetic Variation |
25 | Data Interpretation, Statistical |
25 | DNA Mutational Analysis |
25 | Cognitive Therapy (methods) |
25 | Cognition Disorders (etiology) |
25 | Chi-Square Distribution |
25 | Cell Membrane (metabolism) |
25 | Breast Neoplasms (metabolism) |
25 | Blood Pressure |
25 | Biomarkers |
25 | Anterior Cruciate Ligament Reconstruction (methods) |
25 | Alzheimer Disease (genetics) |
25 | Adolescent Behavior (psychology) |
24 | Women's Health |
24 | Reconstructive Surgical Procedures (methods) |
24 | Peptides (chemistry) |
24 | Pancreatic Neoplasms (pathology) |
24 | Neurons (drug effects) |
24 | Neoplasms (pathology) |
24 | Motivation |
24 | Molecular Structure |
24 | Knee Joint (surgery) |
24 | Intensive Care Units |
24 | Imaging, Three-Dimensional |
24 | Hydrogen-Ion Concentration |
24 | Hospitalization |
24 | Flow Cytometry |
24 | Exercise |
24 | Executive Function (physiology) |
24 | Disability Evaluation |
24 | Cooperative Behavior |
24 | Cardiovascular Diseases (epidemiology) |
24 | CD4-Positive T-Lymphocytes (immunology) |
24 | Aging (psychology) |
23 | Tissue Scaffolds |
23 | Surface Properties |
23 | Structure-Activity Relationship |
23 | Sleep (physiology) |
23 | Single-Blind Method |
23 | Recovery of Function |
23 | Reaction Time |
23 | Postoperative Complications (etiology) |
23 | Models, Psychological |
23 | Liver (metabolism) |
23 | HeLa Cells |
23 | Factor Analysis, Statistical |
23 | Cluster Analysis |
23 | Breast Neoplasms (genetics) |
23 | Blood Pressure (physiology) |
23 | Bipolar Disorder (psychology) |
23 | Biomarkers (analysis) |
23 | Administration, Oral |
22 | Up-Regulation |
22 | Treatment Failure |
22 | Transplantation, Homologous |
22 | Statistics as Topic |
22 | Sleep |
22 | Signal Transduction (genetics) |
22 | Risk Assessment (methods) |
22 | Reverse Transcriptase Polymerase Chain Reaction |
22 | Postoperative Complications (epidemiology) |
22 | Positron-Emission Tomography (methods) |
22 | Macrophages (metabolism) |
22 | Ligands |
22 | Injury Severity Score |
22 | Immunosuppressive Agents (therapeutic use) |
22 | Health Care Surveys |
22 | Head and Neck Neoplasms (pathology) |
22 | HIV-1 (genetics) |
22 | HIV Infections (complications) |
22 | Graft Survival |
22 | Gait (physiology) |
22 | Depressive Disorder, Major (psychology) |
22 | Depression (therapy) |
22 | Calibration |
22 | Bacterial Proteins (metabolism) |
22 | Bacterial Proteins (genetics) |
22 | Antidepressive Agents (therapeutic use) |
22 | Anti-Bacterial Agents (pharmacology) |
22 | Animals, Genetically Modified |
21 | Species Specificity |
21 | Qualitative Research |
21 | Oxidative Stress |
21 | Organ Size |
21 | Neoplasm Recurrence, Local (pathology) |
21 | Molecular Targeted Therapy |
21 | Materials Testing |
21 | Hospital Mortality |
21 | Hepatocytes (metabolism) |
21 | Genetic Association Studies |
21 | Electrocardiography |
21 | Data Collection |
21 | DNA Damage |
21 | Cues |
21 | Chemotherapy, Adjuvant |
21 | Cell Differentiation (physiology) |
21 | African Americans (statistics & numerical data) |
20 | Xenograft Model Antitumor Assays |
20 | Transcription, Genetic |
20 | T-Lymphocytes (immunology) |
20 | Stem Cells (cytology) |
20 | Self Concept |
20 | Proteins (chemistry) |
20 | Prosthesis Design |
20 | Patient Compliance |
20 | Parents (psychology) |
20 | Oxygen (blood) |
20 | Observer Variation |
20 | Neoplasms (metabolism) |
20 | Neoplasms (immunology) |
20 | Neoplasm Grading |
20 | Models, Animal |
20 | Membrane Proteins (genetics) |
20 | Lymph Nodes (pathology) |
20 | Interviews as Topic |
20 | Immunity, Innate |
20 | Hypertension (drug therapy) |
20 | Green Fluorescent Proteins (genetics) |
20 | Gestational Age |
20 | Gene Knockdown Techniques |
20 | Extracellular Matrix (metabolism) |
20 | Electroencephalography |
20 | Drug Discovery |
20 | Diet |
20 | Depression (diagnosis) |
20 | DNA (chemistry) |
20 | Curriculum |
20 | Cell Survival |
20 | Calcium (metabolism) |
20 | Cadaver |
20 | CD8-Positive T-Lymphocytes (immunology) |
20 | Blood Glucose (metabolism) |
20 | Antibodies, Monoclonal (therapeutic use) |
20 | Analgesics, Opioid (therapeutic use) |
20 | Adenocarcinoma (genetics) |
19 | Weight Gain |
19 | Walking (physiology) |
19 | Substance-Related Disorders (psychology) |
19 | Rotation |
19 | Psychomotor Performance (physiology) |
19 | Physician-Patient Relations |
19 | Peer Group |
19 | Patient Education as Topic |
19 | Obesity (epidemiology) |
19 | Neurons (pathology) |
19 | Neoplasm Invasiveness |
19 | Melanoma (pathology) |
19 | Insulin Resistance |
19 | Hypoglycemic Agents (therapeutic use) |
19 | HIV-1 (drug effects) |
19 | HIV Infections (immunology) |
19 | HIV Infections (epidemiology) |
19 | Glucose (metabolism) |
19 | Gene Deletion |
19 | Focus Groups |
19 | Ethnic Groups |
19 | Educational Status |
19 | Disease Management |
19 | Depressive Disorder (psychology) |
19 | Depression (physiopathology) |
19 | Attitude to Health |
19 | Artificial Intelligence |
19 | Age Distribution |
19 | African Americans |
18 | Range of Motion, Articular |
18 | Radiotherapy Dosage |
18 | Rabbits |
18 | Particle Size |
18 | Neoplasms (genetics) |
18 | NF-kappa B (metabolism) |
18 | Macrophages (immunology) |
18 | Lung Transplantation |
18 | Kidney (pathology) |
18 | Inflammation (pathology) |
18 | Infant, Premature |
18 | In Situ Hybridization, Fluorescence |
18 | Image Processing, Computer-Assisted (methods) |
18 | Image Interpretation, Computer-Assisted (methods) |
18 | Hospitalization (statistics & numerical data) |
18 | History, 20th Century |
18 | Hemodynamics |
18 | Heart Failure (physiopathology) |
18 | Health Surveys |
18 | HIV Infections (prevention & control) |
18 | Gene Expression Regulation, Developmental |
18 | European Continental Ancestry Group (genetics) |
18 | Epithelial Cells (metabolism) |
18 | Enzyme Inhibitors (pharmacology) |
18 | Emotions (physiology) |
18 | Dogs |
18 | Dietary Supplements |
18 | Depression (complications) |
18 | DNA-Binding Proteins (metabolism) |
18 | Crystallography, X-Ray |
18 | Cerebrovascular Circulation (physiology) |
18 | Biological Evolution |
18 | Anxiety (psychology) |
18 | Antihypertensive Agents (therapeutic use) |
18 | Adenosine Triphosphate (metabolism) |
18 | Action Potentials (physiology) |
17 | White Matter (pathology) |
17 | Tissue Donors |
17 | Substance-Related Disorders (epidemiology) |
17 | Stroke (etiology) |
17 | Smoking (adverse effects) |
17 | Risk-Taking |
17 | Proto-Oncogene Proteins (genetics) |
17 | Postoperative Period |
17 | Pedigree |
17 | Obesity, Morbid (surgery) |
17 | Neural Pathways (physiology) |
17 | Neoplasms (drug therapy) |
17 | Mobility Limitation |
17 | MicroRNAs (metabolism) |
17 | Lung Neoplasms (drug therapy) |
17 | Lung (immunology) |
17 | Length of Stay (statistics & numerical data) |
17 | Inflammation (immunology) |
17 | Green Fluorescent Proteins (metabolism) |
17 | Genetic Predisposition to Disease (genetics) |
17 | Gene Expression Regulation (drug effects) |
17 | Diabetes Mellitus, Type 2 (complications) |
17 | Depression (etiology) |
17 | Decision Support Techniques |
17 | DNA Repair |
17 | Counseling |
17 | Contrast Media |
17 | Colorectal Neoplasms (pathology) |
17 | Carcinoma, Squamous Cell (genetics) |
17 | Canada |
17 | Breast Neoplasms (surgery) |
17 | Brain Mapping (methods) |
17 | Body Weight |
17 | Antipsychotic Agents (therapeutic use) |
17 | Antineoplastic Agents (adverse effects) |
17 | Anterior Cruciate Ligament Injuries |
17 | Affect |
16 | Water (chemistry) |
16 | Translational Medical Research |
16 | Suicidal Ideation |
16 | Stress, Psychological (psychology) |
16 | Sequence Alignment |
16 | Schizophrenia (pathology) |